The role of platelet/endothelial cell adhesion molecule-1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells

Cancer Research

Volumn 67, Issue 18, 2007, Pages 8624-8632

  Gallay, Nathalie ^a,b   Anani, Ludovic ^b,c   Lopez, Adriana ^a,b   Colombat, Philippe ^a,b,c   Binet, Christian ^a,b,c   Domenech, Jorge ^a,b,c   Weksler, Babette B ^d   Malavasi, Fabio ^e   Herault, Olivier ^a,b,c,f  

^a INSERM   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF TURIN   (Italy)

^f INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIBODY; CD31 ANTIGEN; CD38 ANTIBODY; CD38 ANTIGEN; CELL ADHESION MOLECULE; HYALURONIC ACID; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MEMBRANE; CELL MIGRATION; CELL SURVIVAL; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOPRECIPITATION; IN VITRO STUDY; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MICROENVIRONMENT; OSTEOBLAST; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; ANTIGENS, CD38; BONE MARROW CELLS; CELL ADHESION; CELL MEMBRANE; CELL MOVEMENT; ENDOTHELIAL CELLS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HL-60 CELLS; HUMANS; HYALURONIC ACID; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MIDDLE AGED; U937 CELLS;

EID: 34548740853     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0402     Document Type: Article

References (48)

1. Hazlehurst LA, Landowski TH, Dalton WS. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death. Oncogene 2003;22:7396-402.
2. Inoue S, Osmond DG. Basement membrane of mouse bone marrow sinusoids shows distinctive structure and proteoglycan composition: a high resolution ultrastructural study. Anat Rec 2001;264:294-304.
3. Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990;247:1219-22.
4. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178:449-60.
5. Howard M, Grimaldi JC, Bazan JF, et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 1993;262:1056-9.
6. Nishina H, Inageda K, Takahashi K, Hoshino S, Ikeda K, Katada T. Cell surface antigen CD38 identified as ecto-enzyme of NAD glycohydrolase has hyaluronate-binding activity. Biochem Biophys Res Commun 1994;203:1318-23.
7. Deaglio S, Morra M, Mallone R, et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 1998;160:395-402.
8. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium. J Histochem Cytochem 2004;52:87-101.
9. Hascall VC, Hascall GK. Proteoglycans. In: Hay ED, editor. Cell biology of the extracellular matrix. New York: Plenum Publishing Corp.; 1981. p. 39-63.
10. Schweitzer KM, Vicart P, Delouis C, et al. Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest 1997;76:25-36.
11. Sebestyen Z, Nagy P, Horvath G, et al. Long wavelength fluorophores and cell-by-cell correction for autofluorescence significantly improves the accuracy of flow cytometric energy transfer measurements on a dual-laser benchtop flow cytometer. Cytometry 2002;48:124-35.
12. Krosl J, Sauvageau G. AP-1 complex is effector of Hox-induced cellular proliferation and transformation. Oncogene 2000;19:5134-41.
13. Hardy CL, Minguell JJ. A cytoadhesion assay for the binding of cloned hemopoietic progenitor cells to stroma. Exp Hematol 1993;21:283-8.
14. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
15. Hardwick C, Hoare K, Owens R, et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 1992;117:1343-50.
16. + lymphocytes. Role of the human CD38 molecule. J Immunol 1994;153:952-9.
17. Brouwer RE, Hoefnagel J, Borger van Der Burg B, et al. Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis. Br J Haematol 2001;115:298-308.
18. Deaglio S, Vaisitti T, Aydin S, Ferrero E, Malavasi F. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood 2006;108:1135-44.
19. Zubiaur M, Fernandez O, Ferrero E, et al. CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-ζ immune receptor tyrosine-based activation motifs. J Biol Chem 2002;277:13-22.
20. Morra M, Zubiaur M, Terhorst C, Sancho J, Malavasi F. CD38 is functionally dependent on the TCR/CD3 complex in human T cells. FASEB J 1998;12:581-92.
21. Lund FE, Yu N, Kim KM, Reth M, Howard MC. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J Immunol 1996;157:1455-67.
22. Deaglio S, Zubiaur M, Gregorini A, et al. Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood 2002;99:2490-8.
23. Frasca L, Fedele G, Deaglio S, et al. CD38 orchestrates migration, survival and th1-immune response of human mature dendritic cells. Blood 2006;107:2392-9.
24. Deaglio S, Capobianco A, Bergui L, et al. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 2003;102:2146-55.
25. Ferrero E, Saccucci F, Malavasi F. The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics 1999;49:597-604.
26. Behar E, Chao NJ, Hiraki DD, et al. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 1996;334:286-91.
27. Jaksic O, Paro MM, Kardum Skelin I, Kusec R, Pejsa V, Jaksic B. CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow. Blood 2004;103:1968-9.
28. Morabito F, Mangiola M, Stelitano C, Deaglio S, Callea V, Malavasi F. Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome? Haematologica 2003;88:354-5.
29. Vallario A, Chilosi M, Adami F, et al. Human myeloma cells express the CD38 ligand CD31. Br J Haematol 1999;105:441-4.
30. + stem/progenitor cells to bone marrow. Blood 2004;103:2981-9.
31. Charrad RS, Li Y, Delpech B, et al. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med 1999;5:669-76.
32. Todisco E, Suzuki T, Srivannaboon K, et al. CD38 ligation inhibits normal and leukemic myelopoiesis. Blood 2000;95:535-42.
33. Voermans C, Rood PM, Hordijk PL, Gerritsen WR, van der Schoot CE. Adhesion molecules involved in transendothelial migration of human hematopoietic progenitor cells. Stem Cells 2000;18:435-43.
34. + cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31). Blood 1998;91:1196-205.
35. Gao Y, Camacho LH, Mehta K. Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-γ/interleukin-1β-dependent apoptosis of endothelial cells: Implications in the etiology of retinoic acid syndrome. Leuk Res 2007;31:455-63.
36. + and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood 1997;89:72-80.
37. Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem 2002;277:4581-4.
38. Wong CW, Wiedle G, Ballestrem C, et al. PECAM-1/ CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin αvβ3 in Cis. Mol Biol Cell 2000;11:3109-21.
39. Thompson RD, Wakelin MW, Larbi KY, et al. Divergent effects of platelet-endothelial cell adhesion molecule-1 and β3 integrin blockade on leukocyte transmigration in vivo. J Immunol 2000;165:426-34.
40. Partida-Sanchez S, Goodrich S, Kusser K, Oppenheimer N, Randall TD, Lund FE. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 2004;20:279-91.
41. Partida-Sanchez S, Iribarren P, Moreno-Garcia ME, et al. Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose. J Immunol 2004;172:1896-906.
42. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998;91:4523-30.
43. Mohle R, Schittenhelm M, Failenschmid C, et al. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Br J Haematol 2000;110:563-72.
44. Voermans C, van Heese WP, de Jong I, Gerritsen WR, van Der Schoot CE. Migratory behavior of leukemic cells from acute myeloid leukemia patients. Leukemia 2002;16:650-7.
45. Dommange F, Cartron G, Espanel C, et al. CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia. FASEB J 2006;20:1913-5.
46. Yin T, Li L. The stem cell niches in bone. J Clin Invest 2006;116:1195-201.
47. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 2007;21:304-10.
48. Zeng Z, Samudio IJ, Munsell M, et al. Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias. Mol Cancer Ther 2006;5:3113-21.